Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585156 · ClinicalTrials.gov registry record · Early Phase 1
The Effects of Celecoxib on Bone Ingrowth
A Early Phase 1 study, sponsored by University of Utah.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT00585156 is a Early Phase 1 study that was terminated before completion, run by University of Utah. The registered enrollment target is 9 participants.
The verdict
NCT00585156, a Early Phase 1 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of Celebrex on bone growth into porous coated implants, following postoperative total knee arthroplasty administration of Celebrex for pain relief.
Interventions
- DRUG Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585156
The ClinicalTrials.gov registry entry for NCT00585156 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Celecoxib is the first listed.
NCT00585156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585156 about?
NCT00585156 is a clinical study titled "The Effects of Celecoxib on Bone Ingrowth". The purpose of this study is to evaluate the effect of Celebrex on bone growth into porous coated implants, following postoperative total knee arthroplasty administration of Celebrex for pain relief.
What is the current status of trial NCT00585156?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2008-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00585156?
The interventions under investigation include: Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00585156?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.